Cistanche Deserticola for Regulation of Bone Metabolism:Therapeutic Potential and Molecular Mechanisms on Postmenopausal Osteoporosis
Back to article page
Herbal and Botanical Review|Updated:2023-01-05
|
Cistanche Deserticola for Regulation of Bone Metabolism:Therapeutic Potential and Molecular Mechanisms on Postmenopausal Osteoporosis
Cistanche Deserticola for Regulation of Bone Metabolism:Therapeutic Potential and Molecular Mechanisms on Postmenopausal Osteoporosis
中国结合医学杂志(英文版)2023年29卷第1期 页码:74-80
Affiliations:
1.Department of Orthopaedics/Engineering Research Center of Bone and Joint Precision Medicine/Beijing Key Laboratory of Spinal Disease Research, Peking University Third Hospital,Beijing (100191), China
2.Peking University School of Pharmaceutical Sciences, Beijing (100191), China
Author bio:
Prof. TIAN Hua, E-mail: tianhua@bjmu.edu.cn
Funds:
Key Clinical Projects of Peking University Third Hospital(BYSYZD2019037);National Natural Science Foundation of China(82001481)
Cistanche Deserticola for Regulation of Bone Metabolism:Therapeutic Potential and Molecular Mechanisms on Postmenopausal Osteoporosis[J]. 中国结合医学杂志(英文版), 2023,29(1):74-80.
WANG Cheng, LI Feng, LI Yang, et al. Cistanche Deserticola for Regulation of Bone Metabolism:Therapeutic Potential and Molecular Mechanisms on Postmenopausal Osteoporosis[J]. Chinese Journal of Integrative Medicine, 2023,29(1):74-80.
Cistanche Deserticola for Regulation of Bone Metabolism:Therapeutic Potential and Molecular Mechanisms on Postmenopausal Osteoporosis[J]. 中国结合医学杂志(英文版), 2023,29(1):74-80. DOI: 10.1007/s11655-022-3518-z.
WANG Cheng, LI Feng, LI Yang, et al. Cistanche Deserticola for Regulation of Bone Metabolism:Therapeutic Potential and Molecular Mechanisms on Postmenopausal Osteoporosis[J]. Chinese Journal of Integrative Medicine, 2023,29(1):74-80. DOI: 10.1007/s11655-022-3518-z.
Cistanche Deserticola for Regulation of Bone Metabolism:Therapeutic Potential and Molecular Mechanisms on Postmenopausal Osteoporosis
摘要
Abstract
Osteoporosis is a generalized disease of bone that leads to a loss of bone density and bone mass
destruction of bone microstructure
increased brittleness and therefore fracture. At present
the main treatment of Western medicine is drug therapy such as bisphosphonates
calcitriol
vitamin D
etc. However
long-term use of these drugs may bring some adverse reactions. Chinese herbal medicine
Cistanche deserticola
could regulate bone metabolism by promoting osteoblast activity and inhibiting osteoclast activity with low toxicity and adverse reactions. Therefore
Cistanche deserticola
has attracted increasing attention for its efficacy in the prevention and treatment of osteoporosis in recent years. Here we present a literature review of the molecular pathways involved in osteoporosis and the effects of
Cistanche deserticola
on bone metabolism. Our objective is to clarify the mechanism of
Cistanche deserticola
in the treatment of osteoporosis.
关键词
Keywords
osteoporosisCistanche deserticolabone metabolismChinese medicine
references
Ferrari SL. Prevention of fractures in patients with osteoporosis. Lancet 2018;391:184-186.
Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, et al. Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet 2018;391:741-747.
Black DM, Rosen CJ. Clinical practice. postmenopausal osteoporosis. New Eng J Med 2016;374:254-262.
Cheung AM, Papaioannou A, Morin S, Osteoporosis Canada Scientific Advisory Council. Postmenopausal osteoporosis. New Engl J Med 2016;374:2096.
Compston JE, McClung MR, Leslie WD. Osteoporosis.Lancet 2019;393:364-376.
Kiyoi T. Bone resorption activity in mature osteoclasts.Methods Mol Biol 2018;1868:215-222.
Rizzoli R. Postmenopausal osteoporosis: assessment and management. Best Pract Res Clin Endocrinol Metab 2018;32:739-757.
Leder BZ. Parathyroid hormone and parathyroid hormone-related protein analogs in osteoporosis therapy. Curr Osteoporos Rep 2017;15:110-119.
Weaver CM. The quest for evidence for calcium requirements for bone during pregnancy and lactation. Am J Clin Nutr 2019;109:3-4.
DeLong A, Friedman MA, Tucker SM, Krause AR,Kunselman A, Donahue HJ, et al. Protective effects of controlled mechanical loading of bone in C57BL6/J mice subject to disuse. JBMR Plus 2020;4:e10322.
Rocha-Braz MG, Ferraz-de-Souza B. Genetics of osteoporosis: searching for candidate genes for bone fragility. Arch Endocrinol Metab 2016;60:391-401.
Kelly JJ, Garapati SS. Combination therapies in the treatment of osteoporosis. Curr Opin Endocrinol Diabetes Obes 2019;26:291-295.
Estell EG, Rosen CJ. Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis. Nat Rev Endocrinol 2021;17:31-46.
Karner CM, Long F. Wnt signaling and cellular metabolism in osteoblasts. Cell Mol Life Sci 2017;74:1649-1657.
Ahmadzadeh A, Norozi F, Shahrabi S, Shahjahani M, Saki N. Wnt/beta-catenin signaling in bone marrow niche. Cell Tissue Res 2016;363:321-335.
Meng B, Wu D, Cheng Y, Huang P, Liu Y, Gan L, et al. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-kappaB, MAPK and AKT signaling pathways. Scand J Immunol 2020:e12874.
Ma L, Liu X, Sun G. Aspirin reduces the incidence of postmenopausal osteoporosis in rats through OPG-RANKL-RANK signaling pathway. Minerva Endocrinol 2019;44:408-410.
Zou ML, Chen ZH, Teng YY, Liu SY, Jia Y, Zhang KW,et al. The Smad dependent TGF-beta and BMP signaling pathway in bone remodeling and therapies. Front Mol Biosci 2021;8:593310.
Tang C, Liang D, Qiu Y, Zhu J, Tang G. Omentin 1 induces osteoblast viability and differentiation via the TGFbeta/Smad signaling pathway in osteoporosis. Mol Med Rep 2022;25:1-9.
Li X, Jie Q, Zhang H, Zhao Y, Lin Y, Du J, et al. Disturbed MEK/ERK signaling increases osteoclast activity via the Hedgehog-Gli pathway in postmenopausal osteoporosis.Prog Biophys Mol Bio 2016;122:101-111.
He J, Li X, Wang Z, Bennett S, Chen K, Xiao Z, et al.Therapeutic anabolic and anticatabolic benefits of natural Chinese medicines for the treatment of osteoporosis. Front Pharmacol 2019;10:1344.
Gao Y, Qin G, Wen P, Wang Y, Fu W, He L, et al. Safety assessment of powdered Cistanche deserticola Y. C. Ma by a 90-day feeding test in Sprague-Dawley rats. Drug Chem Toxicol 2017;40:383-389.
Wang T, Zhang X, Xie W. Cistanche deserticola Y. C. Ma,"desert ginseng": a review. Am J Chin Med 2012;40:1123-1141.
Fu Z, Fan X, Wang X, Gao X. Cistanches Herba: an overview of its chemistry, pharmacology, and pharmacokinetics property. J Ethnopharmacol 2018;219:233-247.
Gu L, Xiong WT, Wang C, Sun HX, Li GF, Liu X. Cistanche deserticola decoction alleviates the testicular toxicity induced by hydroxyurea in male mice. Asian J Androl 2013;15:838-840.
Liu Y, Wang H, Yang M, Liu N, Zhao Y, Qi X, et al.Cistanche deserticola polysaccharides protects PC12 cells against OGD/RP-induced injury. Biomed Pharmacother 2018;99:671-680.
Gao Z, Lu Y, Halmurat U, Jing J, Xu D. Study of osteoporosis treatment principles used historically by ancient physicians in Chinese medicine. Chin J Integr Med 2013;19:862-868.
Zhang K, Ma X, He W, Li H, Han S, Jiang Y, et al.Extracts of Cistanche deserticola can antagonize immunosenescence and extend life span in senescence-accelerated mouse prone 8 (SAM-P8) mice. Evid Based Complement Alternat Med 2014;2014:601383.
Jia Y, Guan Q, Guo Y, Du C. Reduction of inflammatory hyperplasia in the intestine in colon cancer-prone mice by water-extract of Cistanche deserticola. Phytother Res 2012;26:812-819.
Zeng H, Huang L, Zhou L, Wang P, Chen X, Ding K. A galactoglucan isolated from of Cistanche deserticola Y.C. Ma. and its bioactivity on intestinal bacteria strains.Carbohydr Polym 2019;223:115038.
Xiong Q, Hase K, Tezuka Y, Tani T, Namba T, Kadota S.Hepatoprotective activity of phenylethanoids from Cistanche deserticola. Planta Med 1998;64:120-125.
Li N, Wang J, Ma J, Gu Z, Jiang C, Yu L, et al.Neuroprotective effects of Cistanches herba therapy on patients with moderate Alzheimer's disease. Evid Based Complement Alternat Med 2015;2015:103985.
Morikawa T, Xie H, Pan Y, Ninomiya K, Yuan D, Jia X,et al. A review of biologically active natural products from a desert plant Cistanche tubulosa. Chem Pharm Bull 2019;67:675-689.
Wang N, Ji S, Zhang H, Mei S, Qiao L, Jin X. Herba Cistanches: anti-aging. Aging Dis 2017;8:740-759.
Li TM, Huang HC, Su CM, Ho TY, Wu CM, Chen WC, et al.Cistanche deserticola extract increases bone formation in osteoblasts. J Pharm Pharmacol 2012;64:897-907.
Zeng JC, Fan YG, Liu JR, Zeng YR, Yi CZ, Yan L.Experimental study of directional differentiation of bone mesenchymal stem cells (BMSCs) to osteoblasts guided by serum containing Cistanche deserticola. J Chin Orthoped Traumatol (Chin) 2010;23:606-608.
Liu J, Yang L, Dong Y, Zhang B, Ma X. Echinacoside, an inestimable natural product in treatment of neurological and other disorders. Molecules 2018;23:23051213.
Wei W, Lan XB, Liu N, Yang JM, Du J, Ma L, et al.Echinacoside alleviates hypoxic-ischemic brain injury in neonatal rat by enhancing antioxidant capacity and inhibiting apoptosis. Neurochem Res 2019;44:1582-1592.
Li S, Jiang H, Gu X. Echinacoside suppresses dexamethasone-induced growth inhibition and apoptosis in osteoblastic MC3T3-E1 cells. Exp Ther Med 2018;16:643-648.
Li F, Yang Y, Zhu P, Chen W, Qi D, Shi X, et al.Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. Fitoterapia 2012;83:1443-1450.
Li F, Yang X, Yang Y, Guo C, Zhang C, Yang Z, et al.Antiosteoporotic activity of echinacoside in ovariectomized rats. Phytomedicine 2013;20:549-557.
Yang X, Li F, Yang Y, Shen J, Zou R, Zhu P, et al. Efficacy and safety of echinacoside in a rat osteopenia model. Evid Based Complement Alternat Med 2013;2013:926928.
Song D, Cao Z, Liu Z, Tickner J, Qiu H, Wang C, et al.Cistanche deserticola polysaccharide attenuates osteoclastogenesis and bone resorption via inhibiting RANKL signaling and reactive oxygen species production.J Cell Physiol 2018;233:9674-9684.
Zhang B, Yang LL, Ding SQ, Liu JJ, Dong YH, Li YT, et al.Anti-osteoporotic activity of an edible traditional Chinese medicine Cistanche deserticola on bone metabolism of ovariectomized rats through RANKL/RANK/TRAF6-mediated signaling pathways. Front Pharmacol 2019;10:1412.
Yang L, Ding S, Zhang B, Liu J, Dong Y, Tang Q, et al. Beneficial effects of total phenylethanoid glycoside fraction isolated from Cistanche deserticola on bone microstructure in ovariectomized rats. Oxid Med Cell Longev 2019;2019:2370862.
Xu X, Zhang Z, Wang W, Yao H, Ma X. Therapeutic effect of cistanoside A on bone metabolism of ovariectomized mice. Molecules 2017;22:22020197.
Yang L, Zhang B, Liu J, Dong Y, Li Y, Li N, et al. Protective effect of acteoside on ovariectomy-induced bone loss in mice. Int J Mol Sci 2019;20:20122974.
Liang HD, Yu F, Tong ZH, Zhang HQ, Liang W. Cistanches Herba aqueous extract affecting serum BGP and TRAP and bone marrow Smad1 mRNA, Smad5 mRNA, TGF-beta1 mRNA and TIEG1 mRNA expression levels in osteoporosis disease. Mol Biol Rep 2013;40:7.
Positive Effects of Qing'e Pill (青娥丸) on Trabecular Microarchitecture and its Mechanical Properties in Osteopenic Ovariectomised Mice
Immunomodulatory Function of Pien Tze Huang in T Cell-Mediated Anti-tumor Activity against B16-F10, MC38 and Hep1-6 Tumor Models
Protective Effects of Phellodendron Species on Bone Health:A Novel Perspective on Their Potentials in Treating Osteoporosis and Osteoarthritis
Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini
Safflower Yellow Inhibits Progression of Hepatocellular Carcinoma by Modulating Immunological Tolerance via FAK Pathway
相关作者
暂无数据
相关机构
Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Science, Xiamen University
Fujian Pien Tze Huang Enterprise Key Laboratory of Natural Medicine Research and Development
Good Clinical Practice Development, Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital of Southern Medical University
Department of Pharmacy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University